Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 29102 in Psoriasis Vulgaris
NCT00875277Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Apr 2009
- Primary completion
- May 2009
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of LEO 29102 cream vehicle in Psoriasis vulgaris (PV) (6 arms), sponsored by LEO Pharma. Primary endpoint: Total Clinical Score at 4 weeks. Started Apr 2009; status: completed.
02
Drugs
LEO 29102 cream vehicle
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00875277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00875277.